Unrated Drug recall · FDA · Published May 11, 2020

BIOTA Biosciences CBD-Curcumin Vial Recall: Unapproved Ingredients Risk Infection

BIOTA Biosciences recalls sterile CBD and curcumin vials due to unapproved ingredients and lack of FDA approval. Consumers should check lot numbers and contact the company for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1329-2020Drug BIOTA Biosciences ›

Recall notice

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Take action

Contact the company

Recalling firmBIOTA Biosciences LLC1601 5th Ave Ste 1100 · Seattle, WA 98101-3603

✎ GovInfoNow plain-language explainer

BIOTA Biosciences is recalling sterile CBD and curcumin vials because they contain unapproved ingredients and were sold without FDA approval. This could lead to infections or other health risks if used improperly. Read more at govinfonow.com/recall/37122-biota-biosciences-cbd-curcumin-vial-recall-unapproved-ingredients-risk-infection.

Source Summary by GovInfoNow · govinfonow.com/recall/37122-biota-biosciences-cbd-curcumin-vial-recall-unapproved-ingredients-risk-infection · Updated October 5, 2026 · FDA enforcement record: FDA #D-1329-2020

Cite this page

“BIOTA Biosciences CBD-Curcumin Vial Recall: Unapproved Ingredients Risk Infection.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37122-biota-biosciences-cbd-curcumin-vial-recall-unapproved-ingredients-risk-infection. Based on FDA recall #D-1329-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1329-2020%22&limit=1).

The FDA announced on May 11, 2020, that BIOTA Biosciences LLC voluntarily recalled Sterile Cannabidiol (CBD) + Curcumin 50mg/mL vials due to lack of sterility assurance and unapproved ingredients. The agency classified the Class II recall under number D-1329-2020.

How to tell if you have it

Brand: BIOTA Biosciences
Product: Sterile Cannabidiol (CBD) + Curcumin 50mg/mL, 10 mL vial
Lot codes: 101019PC, 1010019PC, 10102019PC
Expiration date: 10/10/2021

The hazard

The product lacks assurance of sterility and is marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). The recall addresses the presence of unapproved Cannabidiol and Curcumin in the sterile vials.

Context

GovInfoNow's records show other recent recalls of similar products include Reliance Bortezomib Injection Recall (2026-06-24), BD ChloraPrep Applicators Recall (2026-06-11), and Broadway Joe's Pain Cream Recall (2026-08-21).

How to tell if you have this one

Check the vial for lot numbers 101019PC, 1010019PC, or 10102019PC. The product was sold with an expiration date of 10/10/2021.

Brand
BIOTA Biosciences
Category
Drug

FDA recall event · 5 products

All 5 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Terminated
Distribution
Nationwide within the United States and New Zealand

Recall number	Product, codes & lots
D-1326-2020	Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial; Lot #: 2H071219P, 2H0712019P, 2H07122019P, Exp. Date 7/12/2021
D-1327-2020	Sterile Curcumin, 4mg/mL, 10mL vial; Lot #: 2H071219CCD, 2H0712019CCD, 2H07122019CCD, Exp. Date 7/12/2021
D-1328-2020	Sterile Cannabidiol (CBD) 50mg/mL, 10mL vial; Lot #: 101019P, 1010019P,10102019P, Exp. Date 10/10/2021
D-1329-2020	Sterile Cannabidiol (CBD) + Curcumin 50mg/mL, 10 mL vial; Lot #: 101019PC, 1010019PC, 10102019PC, Exp. Date 10/10/2021
D-1330-2020	Sterile Curcumin 50mg/mL, 10 mL vial; Lot #: 071219CCD, 0712019CCD, 07122019CCD, Exp. Date 7/12/2021

Based on the official FDA remedy

What to do — step by step

Check Vial Lot Number
Look for lot numbers 101019PC, 1010019PC, or 10102019PC on the vial label.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide within the United States and New Zealand” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

May 11, 2020Firm started the recall
Jun 19, 2020FDA classified it Class II
Jul 1, 2020Published in FDA’s Enforcement Report
Dec 3, 2020FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/37122-biota-biosciences-cbd-curcumin-vial-recall-unapproved-ingredients-risk-infection">BIOTA Biosciences CBD-Curcumin Vial Recall: Unapproved Ingredients Risk Infection (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1329-2020 (May 11, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1329-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.